Annual Accounts Receivable
$12.80 M
+$2.14 M+20.07%
30 November 2023
Summary:
Theratechnologies annual accounts receivable is currently $12.80 million, with the most recent change of +$2.14 million (+20.07%) on 30 November 2023. During the last 3 years, it has risen by +$3.54 million (+38.19%). THTX annual accounts receivable is now at all-time high.THTX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$10.31 M
-$2.54 M-19.75%
31 August 2024
Summary:
Theratechnologies quarterly accounts receivable is currently $10.31 million, with the most recent change of -$2.54 million (-19.75%) on 31 August 2024. Over the past year, it has dropped by -$2.48 million (-19.40%). THTX quarterly accounts receivable is now -24.32% below its all-time high of $13.63 million, reached on 28 February 2022.THTX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
THTX Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -19.4% |
| 3 y3 years | +38.2% | +11.4% |
| 5 y5 years | +34.2% | +8.2% |
THTX Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +38.2% | -24.3% | +18.8% |
| 5 y | 5 years | at high | +38.2% | -24.3% | +24.6% |
| alltime | all time | at high | +8005.1% | -24.3% | >+9999.0% |
Theratechnologies Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Aug 2024 | - | $10.31 M(-19.8%) |
| May 2024 | - | $12.85 M(+28.6%) |
| Feb 2024 | - | $10.00 M(-21.9%) |
| Nov 2023 | $12.80 M(+20.1%) | $12.80 M(+47.4%) |
| Aug 2023 | - | $8.68 M(-33.8%) |
| May 2023 | - | $13.12 M(+31.1%) |
| Feb 2023 | - | $10.01 M(-6.1%) |
| Nov 2022 | $10.66 M(+15.1%) | $10.66 M(-5.9%) |
| Aug 2022 | - | $11.32 M(-9.3%) |
| May 2022 | - | $12.48 M(-8.5%) |
| Feb 2022 | - | $13.63 M(+47.2%) |
| Nov 2021 | $9.26 M(-15.4%) | $9.26 M(-29.3%) |
| Aug 2021 | - | $13.11 M(+26.6%) |
| May 2021 | - | $10.35 M(-4.1%) |
| Feb 2021 | - | $10.79 M(-1.4%) |
| Nov 2020 | $10.95 M(+14.8%) | $10.95 M(+32.3%) |
| Aug 2020 | - | $8.28 M(-32.1%) |
| May 2020 | - | $12.19 M(+23.3%) |
| Feb 2020 | - | $9.89 M(+3.6%) |
| Nov 2019 | $9.54 M(-11.0%) | $9.54 M(-16.1%) |
| Aug 2019 | - | $11.37 M(-15.3%) |
| May 2019 | - | $13.42 M(+68.1%) |
| Feb 2019 | - | $7.99 M(-25.5%) |
| Nov 2018 | $10.72 M(+43.7%) | $10.72 M(-7.9%) |
| Aug 2018 | - | $11.64 M(+48.7%) |
| May 2018 | - | $7.83 M(+53.8%) |
| Feb 2018 | - | $5.09 M(-31.8%) |
| Nov 2017 | $7.46 M(+50.2%) | $7.46 M(+9.9%) |
| Aug 2017 | - | $6.79 M(+14.4%) |
| May 2017 | - | $5.93 M(+29.4%) |
| Feb 2017 | - | $4.59 M(-7.7%) |
| Nov 2016 | $4.97 M(+48.3%) | $4.97 M(-6.3%) |
| Aug 2016 | - | $5.30 M(-4.8%) |
| May 2016 | - | $5.57 M(+28.3%) |
| Feb 2016 | - | $4.34 M(+29.6%) |
| Nov 2015 | $3.35 M(+67.5%) | $3.35 M(-26.6%) |
| Aug 2015 | - | $4.56 M(+36.6%) |
| May 2015 | - | $3.34 M(+64.7%) |
| Feb 2015 | - | $2.03 M(+1.4%) |
| Nov 2014 | $2.00 M(+377.2%) | $2.00 M(+2761.4%) |
| Aug 2014 | - | $69.90 K(-48.8%) |
| May 2014 | - | $136.40 K(-48.2%) |
| Feb 2014 | - | $263.30 K(-37.2%) |
| Nov 2013 | $419.10 K(-60.2%) | $419.10 K(-34.4%) |
| Aug 2013 | - | $639.30 K(-48.9%) |
| May 2013 | - | $1.25 M(+70.8%) |
| Feb 2013 | - | $732.60 K(-30.4%) |
| Nov 2012 | $1.05 M(-20.4%) | $1.05 M(+1061.1%) |
| Aug 2012 | - | $90.60 K(-89.6%) |
| May 2012 | - | $875.30 K(+159.0%) |
| Feb 2012 | - | $337.90 K(-74.4%) |
| Nov 2011 | $1.32 M(+736.5%) | $1.32 M(-46.8%) |
| Aug 2011 | - | $2.48 M(+47.6%) |
| May 2011 | - | $1.68 M(+18.2%) |
| Feb 2011 | - | $1.42 M(+802.0%) |
| Nov 2010 | $157.90 K | $157.90 K(+27.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Aug 2010 | - | $123.50 K(-26.0%) |
| May 2010 | - | $166.80 K(-37.6%) |
| Feb 2010 | - | $267.30 K(-24.6%) |
| Nov 2009 | $354.50 K(-27.8%) | $354.50 K(+76.5%) |
| Aug 2009 | - | $200.90 K(-20.7%) |
| May 2009 | - | $253.20 K(-42.5%) |
| Feb 2009 | - | $440.30 K(-10.4%) |
| Nov 2008 | $491.20 K(+9.0%) | $491.20 K(-11.6%) |
| Aug 2008 | - | $555.40 K(+72.6%) |
| May 2008 | - | $321.80 K(-5.9%) |
| Feb 2008 | - | $341.80 K(-24.2%) |
| Nov 2007 | $450.80 K(+78.0%) | $450.80 K(-39.3%) |
| Aug 2007 | - | $743.20 K(+45.3%) |
| May 2007 | - | $511.50 K(+4.7%) |
| Feb 2007 | - | $488.70 K(+93.0%) |
| Nov 2006 | $253.20 K(+14.6%) | $253.20 K(-6.7%) |
| Aug 2006 | - | $271.40 K(+0.6%) |
| May 2006 | - | $269.70 K(-14.8%) |
| Feb 2006 | - | $316.40 K(+43.2%) |
| Nov 2005 | $220.90 K(-33.6%) | $220.90 K(-32.5%) |
| Aug 2005 | - | $327.50 K(+19.1%) |
| May 2005 | - | $274.90 K(-22.0%) |
| Feb 2005 | - | $352.50 K(+6.0%) |
| Nov 2004 | $332.70 K(-6.7%) | $332.70 K(+88.3%) |
| Aug 2004 | - | $176.70 K(-60.6%) |
| May 2004 | - | $448.50 K(+11.7%) |
| Feb 2004 | - | $401.70 K(+12.6%) |
| Nov 2003 | $356.70 K(-8.2%) | $356.70 K(+21.0%) |
| Aug 2003 | - | $294.70 K(-35.0%) |
| May 2003 | - | $453.20 K(+31.6%) |
| Feb 2003 | - | $344.40 K(-11.4%) |
| Nov 2002 | $388.50 K(-14.3%) | $388.50 K(-23.6%) |
| Aug 2002 | - | $508.20 K(-6.4%) |
| May 2002 | - | $543.20 K(-60.4%) |
| Feb 2002 | - | $1.37 M(+203.0%) |
| Nov 2001 | $453.30 K(-70.6%) | $453.30 K(+67.3%) |
| Aug 2001 | - | $271.00 K(-76.8%) |
| May 2001 | - | $1.17 M(-25.8%) |
| Feb 2001 | - | $1.58 M(+2.1%) |
| Nov 2000 | $1.54 M(+51.6%) | $1.54 M(+36.5%) |
| Aug 2000 | - | $1.13 M(-26.3%) |
| May 2000 | - | $1.53 M(-3.2%) |
| Feb 2000 | - | $1.58 M(+55.6%) |
| Nov 1999 | $1.02 M(+30.4%) | $1.02 M(+117.5%) |
| Aug 1999 | - | $468.40 K(-23.3%) |
| May 1999 | - | $610.40 K(-42.5%) |
| Feb 1999 | - | $1.06 M(+35.8%) |
| Nov 1998 | $781.30 K(+11.2%) | $781.30 K(-46.3%) |
| Aug 1998 | - | $1.46 M(+6.0%) |
| May 1998 | - | $1.37 M(+39.6%) |
| Feb 1998 | - | $983.70 K(+40.0%) |
| Nov 1997 | $702.70 K(-78.5%) | $702.70 K(-2.4%) |
| Aug 1997 | - | $719.90 K(-38.0%) |
| May 1997 | - | $1.16 M(+32.4%) |
| Feb 1997 | - | $876.80 K |
| Nov 1996 | $3.27 M | - |
FAQ
- What is Theratechnologies annual accounts receivable?
- What is the all time high annual accounts receivable for Theratechnologies?
- What is Theratechnologies quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Theratechnologies?
- What is Theratechnologies quarterly accounts receivable year-on-year change?
What is Theratechnologies annual accounts receivable?
The current annual accounts receivable of THTX is $12.80 M
What is the all time high annual accounts receivable for Theratechnologies?
Theratechnologies all-time high annual accounts receivable is $12.80 M
What is Theratechnologies quarterly accounts receivable?
The current quarterly accounts receivable of THTX is $10.31 M
What is the all time high quarterly accounts receivable for Theratechnologies?
Theratechnologies all-time high quarterly accounts receivable is $13.63 M
What is Theratechnologies quarterly accounts receivable year-on-year change?
Over the past year, THTX quarterly accounts receivable has changed by -$2.48 M (-19.40%)